Past, present, and future of Endovascular stroke therapies

Neurology

Volumn 79, Issue 13 SUPPL. 1, 2012, Pages

  Taqi, M A ^a   Vora, N ^b   Callison, R C ^b   Lin, R ^b   Wolfe, T J ^a  

^a DESERT REGIONAL MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALFIMEPRASE; ALTEPLASE; ANCROD; BB 101153; DESMOTEPLASE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; PROUROKINASE; RETEPLASE; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR DERIVATIVE; UNCLASSIFIED DRUG; UROKINASE; V 101153; BB 10153; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR; V 10153;

ANGIOPLASTY; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CATHETER; CLINICAL EFFECTIVENESS; DRUG DOSE ESCALATION; DRUG MEGADOSE; DRUG SAFETY; ENDOVASCULAR SURGERY; HEPARINIZATION; HUMAN; LOW DRUG DOSE; MEDICAL TECHNOLOGY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RECANALIZATION; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; STENT; THROMBECTOMY; ADJUVANT THERAPY; ARTERY DISSECTION; ARTICLE; BALLOON CATHETER; BOAR (MALE PIG); BRAIN BLOOD FLOW; BRAIN EMBOLISM; CEREBROVASCULAR ACCIDENT; DEVICE APPROVAL; DEVICE SAFETY; DEVICES; DRUG APPROVAL; EMBOLECTOMY; FOOD AND DRUG ADMINISTRATION; NON INVASIVE SURGICAL DEVICE; VENOUS REFLUX;

EID: 84867565526     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826959e5     Document Type: Article

References (39)

1. Del Zoppo GJ, Ferbert A, Otis S, et al. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke 1988;19:307-313.
2. Zeumer H, Hacke W, Ringelstein EB. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am J Neuroradiol 1983;4:401-404.
3. Del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT investigators: Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11.
4. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011.
5. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007;38:2633-2639.
6. Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-1231.
7. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.
8. Liebeskind DS. Reversing stroke in the 2010s: lessons from Desmoteplase in Acute Ischemic Stroke-2 (DIAS-2). Stroke 2009;40:3156-3158.
9. Marder VJ, Blinc A, Gruber T et al. Comparison of plasmin with recombinant tissue-type plasminogen activator in lysis of cerebral thromboemboli retrieved from patients with acute ischemic stroke. Stroke 2011;42:2222-2228.
10. Thijs VN, Peeters A, Vosko M et al. Randomized, placebo-controlled, dose-ranging clinical trial of intravenous microplasmin in patients with acute ischemic stroke. Stroke 2009;40:3789-3795.
11. The Ancrod Stroke Study Investigators. Ancrod for the treatment of acute ischemic brain infarction. Stroke 1994;25:1755-1759.
12. Khatri P, Hill MD, Palesch YY, et al. Methodology of the Interventional Management of Stroke III trial. Int J Stroke 2008;3:130-137.
13. Adams HP Jr, Effron MB, Torner J, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008;39:87-99.
14. Pancioli AM, Broderick J, Brott T, et al. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke 2008;39:3268-3276.
15. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction. description of a new technic and a preliminary report of its application. Circulation 1964;30:654-670.
16. Tsai FY, Berberian B, Matovich V, Lavin M, Alfieri K. Percutaneous transluminal angioplasty adjunct to thrombolysis for acute middle cerebral artery rethrombosis. AJNR Am J Neuroradiol 1994;15:1823-1829.
17. Janjua N, Alkawi A, Suri MF, Qureshi AI. Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke. AJNR Am J Neuroradiol 2008;29:253-258.
18. Wright KC, Wallace S, Charnsangavej C, Carrasco CH, Gianturco C. Percutaneous endovascular stents: an experimental evaluation. Radiology 1985;156:69-72.
19. Levy EI, Mehta R, Gupta R, et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007;28:816-822.
20. Kelly ME, Furlan AJ, Fiorella D. Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass. Stroke 2008;39:1770-1773.
21. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-1438.
22. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial. Stroke 2008;39:1205-1212.
23. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-2768.
24. Fussell D, Schumacher HC, Meyers PM, Higashida RT. Mechanical interventions to treat acute stroke. Curr Neurol Neurosci Rep 2007;7:21-27.
25. Brekenfeld C, Schroth G, El-Koussy M, et al. Mechanical thromboembolectomy for acute ischemic stroke: comparison of the Catch thrombectomy device and the Merci retriever in vivo. Stroke 2008;39:1213-1219.
26. Mourand I, Brunel H, Costalat V, et al. Mechanical thrombectomy in acute ischemic stroke: Catch device. AJNR Am J Neuroradiol 2011;32:1381-1385.
27. Henkes H, Reinartz J, Lowens S, et al. A device for fast mechanical clot retrieval from intracranial arteries (phenox clot retriever). Neurocrit Care 2006;5:134-140.
28. Mordasini P, Hiller M, Brekenfeld C, et al. In vivo evaluation of the phenox CRC mechanical thrombectomy device in a swine model of acute vessel occlusion. AJNR Am J Neuroradiol 2010;31:972-978.
29. Kerber CW, Wanke I, Bernard Jr, Woo HH, Liu MW, Nelson PK. Rapid intracranial clot removal with a new device: the alligator retriever. AJNR Am J Neuroradiol 2007;28:860-863.
30. Bellon RJ, Putman CM, Budzik RF, Pergolizzi RS, Reinking GF, Norbash AM. Rheolytic thrombectomy of the occluded internal carotid artery in the setting of acute ischemic stroke. AJNR Am J Neuroradiol 2001;22:526-530.
31. Mahon BR, Nesbit GM, Barnwell SL, et al. North American clinical experience with the Ekos MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 2003;24:534-538.
32. Berlis A, Lutsep H, Barnwell S, et al. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 2004;35:1112-1116.
33. Castano C, Dorado L, Guerrero C, et al. Mechanical thrombectomy with the solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:1836-1840.
34. Roth C, Papanagiotou P, Behnke S, et al. Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 2010;41:2559-2567.
35. Wehrschuetz M, Wehrschuetz E, Augustin M, Niederkorn K, Deutschmann H, Ebner F. Early single center experience with the solitaire thrombectomy device for the treatment of acute ischemic stroke. Interv Neuroradiol 2011;17:235-240.
36. Brekenfeld C, Schroth G, Mordasini P, et al. Impact of retrievable stents on acute ischemic stroke treatment. AJNR Am J Neuroradiol 2011;32:1269-1273.
37. Liebeskind DS. Aortic occlusion for cerebral ischemia: from theory to practice. Curr Cardiol Rep 2008;10:31-36.
38. Shuaib A, Bornstein NM, Diener HC, et al. Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in acute ischemic stroke trial. Stroke 2011;42:1680-1690.
39. Nogueira RG, Schwamm LH, Hirsch JA. Endovascular approaches to acute stroke, part 1: drugs, devices, and data. AJNR Am J Neuroradiol 2009;30:649-661.